Table 3_cAMP-MFN2 signaling suppresses cochlear cell senescence and age-related hearing loss.docx

Table 3_cAMP-MFN2 signaling suppresses cochlear cell senescence and age-related hearing loss.docx

Introduction<p>Age-related hearing loss (presbycusis) is the most common sensory deficit in the elderly, yet it lacks effective pharmacological treatments. The decline of the cyclic AMP (cAMP) signaling pathway is implicated in aging, but its functional role in the auditory system remains larg...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Yu Liu (6938) (author)
Autres auteurs:	Jinyuan Cao (11506260) (author), Jie Cui (198388) (author), Haitong Chen (20830751) (author), Shujing Qin (11862449) (author), Qi Li (67548) (author), Zhongwu Su (499868) (author)
Publié:	2025
Sujets:	Genetic Immunology age-related hearing loss (ARHL) cAMP mitofusin2 mitochondrial dynamics inflammation
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Table 2_cAMP-MFN2 signaling suppresses cochlear cell senescence and age-related hearing loss.docx
par: Yu Liu (6938)
Publié: (2025)

Table 1_cAMP-MFN2 signaling suppresses cochlear cell senescence and age-related hearing loss.xlsx
par: Yu Liu (6938)
Publié: (2025)

Supplementary file 2_Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway.docx
par: Junming Xu (1716112)
Publié: (2025)

Supplementary file 1_Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway.zip
par: Junming Xu (1716112)
Publié: (2025)

Table 6_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.xlsx
par: Zhi-qiang Zhang (4587796)
Publié: (2025)

Table 5_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.xlsx
par: Zhi-qiang Zhang (4587796)
Publié: (2025)

Table 3_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.xlsx
par: Zhi-qiang Zhang (4587796)
Publié: (2025)

Table 4_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.xlsx
par: Zhi-qiang Zhang (4587796)
Publié: (2025)

Table 1_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.docx
par: Zhi-qiang Zhang (4587796)
Publié: (2025)

Table 2_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.xlsx
par: Zhi-qiang Zhang (4587796)
Publié: (2025)

Supplementary file 1_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.docx
par: Zhi-qiang Zhang (4587796)
Publié: (2025)

Differential impact of EBOV and MARV on cAMP-mediated function in human gut organoids reveals region-specific loss of forskolin-induced swelling in HCOs.
par: Elizabeth Y. Flores (22676699)
Publié: (2025)

Elamipretide: First Approval
par: Matt Shirley (7340599)
Publié: (2025)

Table 1_Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study.doc
par: Chen Pengfei (22675154)
Publié: (2025)

Image 3_Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study.tif
par: Chen Pengfei (22675154)
Publié: (2025)

Image 4_Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study.tif
par: Chen Pengfei (22675154)
Publié: (2025)

Image 1_Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study.tif
par: Chen Pengfei (22675154)
Publié: (2025)

Image 2_Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study.tif
par: Chen Pengfei (22675154)
Publié: (2025)

<b>Morin alleviates fructose-driven disturbance of podocyte mitochondrial energy metabolism by inhibiting AMPD activity to improve glomerular injury</b>
par: Luyi Huang (22583081)
Publié: (2025)

Additional file 12 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
par: Thomas C. Clark (13318734)
Publié: (2025)

Additional file 10 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
par: Thomas C. Clark (13318734)
Publié: (2025)

Additional file 9 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
par: Thomas C. Clark (13318734)
Publié: (2025)

Additional file 6 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
par: Thomas C. Clark (13318734)
Publié: (2025)

Additional file 4 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
par: Thomas C. Clark (13318734)
Publié: (2025)

Additional file 3 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
par: Thomas C. Clark (13318734)
Publié: (2025)

Additional file 2 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
par: Thomas C. Clark (13318734)
Publié: (2025)

Additional file 1 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
par: Thomas C. Clark (13318734)
Publié: (2025)

Table 1_Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study.docx
par: Lifang Hu (841297)
Publié: (2025)

Table 1_Study on the effect of different types of sugar on proliferation and inflammatory in goose fatty liver.docx
par: Shuang Yi (8698824)
Publié: (2025)

Supplementary file 1_Adopting orphan receptors: zebrafish Tlr4 homologs mediate responses to group IX/X transition metals.docx
par: Aaron P.D. Fox (22686512)
Publié: (2025)

<b>Excessive Lipolysis and Inflammatory Response in Adipose Tissue Are Associated with Elevated Serum Growth Hormone in Dairy Cows with Clinical Ketosis</b>
par: Xinxing Gao (22653201)
Publié: (2025)

Table 1_Gut microbiota alterations and systemic inflammation in community-acquired pneumonia: a prospective gut-lung axis study.docx
par: Xue-Qin Yang (3494345)
Publié: (2025)

Table 7_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
par: Fuxing Lin (7418234)
Publié: (2025)

Table 1_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.docx
par: Fuxing Lin (7418234)
Publié: (2025)

Table 5_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
par: Fuxing Lin (7418234)
Publié: (2025)

Table 6_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
par: Fuxing Lin (7418234)
Publié: (2025)

Image 1_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.tif
par: Fuxing Lin (7418234)
Publié: (2025)

Image 2_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.tif
par: Fuxing Lin (7418234)
Publié: (2025)

Table 3_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
par: Fuxing Lin (7418234)
Publié: (2025)

Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
par: Fuxing Lin (7418234)
Publié: (2025)

Cannot write session to /tmp/vufind_sessions/sess_eobcqq57et4qqr7es8i1ft2bbt